Annual Accounts Payable
$3.79 M
+$1.12 M+41.67%
December 31, 2023
Summary
- As of February 7, 2025, LXEO annual accounts payable is $3.79 million, with the most recent change of +$1.12 million (+41.67%) on December 31, 2023.
- During the last 3 years, LXEO annual accounts payable has risen by +$3.75 million (+8464.33%).
- LXEO annual accounts payable is now at all-time high.
Performance
LXEO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$8.44 M
+$2.67 M+46.37%
September 30, 2024
Summary
- As of February 7, 2025, LXEO quarterly accounts payable is $8.44 million, with the most recent change of +$2.67 million (+46.37%) on September 30, 2024.
- Over the past year, LXEO quarterly accounts payable has increased by +$5.78 million (+217.82%).
- LXEO quarterly accounts payable is now at all-time high.
Performance
LXEO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
LXEO Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +41.7% | +217.8% |
| 3 y3 years | +8464.3% | +217.8% |
| 5 y5 years | +8464.3% | +217.8% |
LXEO Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +41.7% | at high | +256.2% |
| 5 y | 5-year | at high | +8464.3% | at high | +256.2% |
| alltime | all time | at high | +8464.3% | at high | +256.2% |
Lexeo Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $8.44 M(+46.4%) |
| Jun 2024 | - | $5.76 M(+34.2%) |
| Mar 2024 | - | $4.30 M(+13.3%) |
| Dec 2023 | $3.79 M | $3.79 M(+42.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $2.65 M(+12.1%) |
| Jun 2023 | - | $2.37 M(-11.5%) |
| Dec 2022 | $2.68 M(-12.5%) | $2.68 M |
| Dec 2021 | $3.06 M(+6809.7%) | - |
| Dec 2020 | $44.30 K | - |
FAQ
- What is Lexeo Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Lexeo Therapeutics?
- What is Lexeo Therapeutics annual accounts payable year-on-year change?
- What is Lexeo Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Lexeo Therapeutics?
- What is Lexeo Therapeutics quarterly accounts payable year-on-year change?
What is Lexeo Therapeutics annual accounts payable?
The current annual accounts payable of LXEO is $3.79 M
What is the all time high annual accounts payable for Lexeo Therapeutics?
Lexeo Therapeutics all-time high annual accounts payable is $3.79 M
What is Lexeo Therapeutics annual accounts payable year-on-year change?
Over the past year, LXEO annual accounts payable has changed by +$1.12 M (+41.67%)
What is Lexeo Therapeutics quarterly accounts payable?
The current quarterly accounts payable of LXEO is $8.44 M
What is the all time high quarterly accounts payable for Lexeo Therapeutics?
Lexeo Therapeutics all-time high quarterly accounts payable is $8.44 M
What is Lexeo Therapeutics quarterly accounts payable year-on-year change?
Over the past year, LXEO quarterly accounts payable has changed by +$5.78 M (+217.82%)